Insight Molecular Diagnostics (IMDX) Cash from Financing Activities (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Cash from Financing Activities of $24.7 million for Q1 2026, up 9900.79% sequentially from -$252000.0 in Q4 2025, and down 13.52% YoY from $28.6 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Cash from Financing Activities data on file, last reported at $24.7 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 13.52% year-over-year to $24.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.2 million (down 50.57% YoY) and the FY2025 annual result came in at $28.1 million, up 37.41% from the prior year.
- Cash from Financing Activities climbed to $24.7 million in Q1 2026 per IMDX's latest filing, from -$252000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $36.8 million in Q2 2022, with the low at -$528000.0 in Q3 2022.
- Average Cash from Financing Activities over 5 years is $7.6 million, with a median of -$30000.0 recorded in 2023.
- The widest YoY moves for Cash from Financing Activities: up 36223.33% in 2024, down 750.0% in 2024.
- Insight Molecular Diagnostics' Cash from Financing Activities stood at -$100000.0 in 2022, then soared by 70.0% to -$30000.0 in 2023, then jumped by 36223.33% to $10.8 million in 2024, then tumbled by 102.33% to -$252000.0 in 2025, then soared by 9900.79% to $24.7 million in 2026.
- Business Quant data shows IMDX's Cash from Financing Activities at $24.7 million in Q1 2026, -$252000.0 in Q4 2025, and -$120000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 24.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.70 Mn |
| Mar 31, 2026 | 24.70 Mn |
| Dec 31, 2025 | -252,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | 28.56 Mn |
| Mar 31, 2025 | 28.56 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | -255,000.00 |
| Sep 30, 2024 | -255,000.00 |
| Jun 30, 2024 | 9.85 Mn |
| Jun 30, 2024 | 9.85 Mn |
| Dec 31, 2023 | -30,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -30,000.00 |
| Sep 30, 2023 | -30,000.00 |